Global Brachytherapy Market Overview and Trends
- Get link
- X
- Other Apps
Brachytherapy is a type of radiotherapy that is used to treat cancers of all types. Internal radiation, or seed therapy, is another name for it. Unlike external beam radiotherapy, which distributes radiation from the outside, brachytherapy precisely targets the dangerous tumour from the inside. Radioactive seeds are implanted into malignant tissue and positioned in such a way that they will most effectively destroy the tumour. The use of brachytherapy to target malignant cells decreases the danger of harm to healthy tissues and organs surrounding the tumour, as well as the possibility of adverse effects. Brachytherapy is used to treat malignancies of the prostate, cervix, breast, and skin, as well as tumours in other parts of the body such the head and neck. Furthermore, it is frequently used in conjunction with chemotherapy medications to reduce the chance of cancer recurrence. Permanent and temporary brachytherapy are the two types of brachytherapy.
The brachytherapy industry is
primarily driven by the rising incidence of prostate cancer occurrences.
According to the American Cancer Society, around 161,370 people in the United
States were diagnosed with prostate cancer in 2017, with approximately 26,730
deaths related to prostate cancer. In the United States, prostate cancer is the
third greatest cause of death among males. The expanding acceptance of high
dose rate brachytherapy and the rising prevalence of obesity are two key
reasons driving the brachytherapy industry forward. However, radiation therapy side
effects such as hair loss, fatigue, appetite loss, and nausea are likely to
stifle the brachytherapy
market's expansion.
Brachytherapy Market |
Between 2015 and 2020, the global brachytherapy market grew at a
moderate rate. Brachytherapy, also known as internal radiation therapy, is
a type of radiotherapy in which radiation is delivered directly to a cancerous
tumour in the body via a source placed close or next to it. The source emits
gamma rays that target cancer cells while minimising damage to healthy tissue
nearby. Small radioactive seeds are permanently implanted in or around the
tumour in LDR, whereas radioactive sources are removed from the patient's body
at the end of each session in HDR, which is employed in the event of high-risk
tumours.
- Get link
- X
- Other Apps
Comments
Post a Comment